This inventor holds 2 USPTO granted patents. Top assignee: Hangzhou Polymed Biopharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Xiang: Innovator in Pharmaceutical Compounds
Introduction
Michael Xiang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents to his name, his work focuses on compounds that have therapeutic applications.
Latest Patents
Michael's latest patents include a five-membered-fused six-membered compound, along with its preparation method, pharmaceutical composition, and use. This compound exhibits an inhibition or degradation effect on IRAK4. Another patent involves a five-membered-fused six-membered compound, which also demonstrates an inhibitory effect on FLT3 and/or IRAK4. These innovations highlight his commitment to advancing pharmaceutical science.
Career Highlights
Michael Xiang is currently employed at Hangzhou Polymed Biopharmaceuticals, Inc. His role at the company allows him to apply his expertise in developing new pharmaceutical solutions. His contributions are vital to the ongoing research and development efforts within the organization.
Collaborations
Michael collaborates with talented coworkers, including Jason Shaoyun Xiang and Lei Wu. Their combined efforts contribute to the innovative environment at Hangzhou Polymed Biopharmaceuticals, Inc.
Conclusion
Michael Xiang is a prominent inventor whose work in pharmaceutical compounds is paving the way for new therapeutic options. His patents reflect a deep understanding of complex chemical interactions and their potential applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile